UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of residual mass size on response to chemotherapy after surgical cytoreduction for advanced ovarian cancer: Long‐term results

International journal of gynecological cancer, 2002-07, Vol.12 (4), p.323-331

2002

Volltextzugriff (PDF)

Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses

Obstetrics and gynecology (New York. 1953), 1988-10, Vol.72 (4), p.659

1988

Volltextzugriff (PDF)

A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma

Cancer Immunology, Immunotherapy, 2003-04, Vol.52 (4), p.243-248

2003

Volltextzugriff (PDF)

Mucinous Adenocarcinomas of the Vulva

Gynecologic oncology, 1995-04, Vol.57 (1), p.117-120

1995

Volltextzugriff (PDF)

Paraovarian leiomyosarcoma with scalp metastasis: a case report

European journal of gynaecological oncology, 2009, Vol.30 (5), p.566-567

2009

Volltextzugriff (PDF)

Clinical utility of CA 125 in preoperative diagnosis of patients with pelvic masses

European journal of obstetrics & gynecology and reproductive biology, 1993-04, Vol.49 (1), p.105-107

Finkler, N.J.

1993

Volltextzugriff (PDF)

Sonographic accuracy in the diagnosis of ovarian masses

Journal of reproductive medicine, 1990-05, Vol.35 (5), p.491

1990

Volltextzugriff (PDF)

Placental site trophoblastic tumor. Diagnosis, clinical behavior and treatment

Journal of reproductive medicine, 1991-01, Vol.36 (1), p.27

Finkler, N J

1991

Volltextzugriff (PDF)

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

Gynecologic oncology, 2012-12, Vol.127 (3), p.538-543

2012

Volltextzugriff (PDF)

Colouterine fistula complicating diverticulitis: charcoal challenge test aids in diagnosis

Obstetrics and gynecology (New York. 1953), 1992-09, Vol.80 (3 Pt 2), p.550

1992

Volltextzugriff (PDF)

Clinical experience with placental site trophoblastic tumors at the New England Trophoblastic Disease Center

Obstetrics and gynecology (New York. 1953), 1988-06, Vol.71 (6 Pt 1), p.854

1988

Volltextzugriff (PDF)

Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125

Gynecologic oncology, 1992-06, Vol.45 (3), p.265-272

1992

Volltextzugriff (PDF)

Occult pleural involvement in Stage III ovarian carcinoma: Role of diaphragm resection

Gynecologic oncology, 1990-11, Vol.39 (2), p.135-138

1990

Volltextzugriff (PDF)

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC)

Journal of clinical oncology, 2011-06, Vol.29 (18_suppl), p.LBA5007-LBA5007

2011

Volltextzugriff (PDF)

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.LBA5007-LBA5007

2011

Volltextzugriff (PDF)

Chemoradiation followed by adjuvant hysterectomy for the treatment of stage IB-2 cervical cancer: 10-year experience

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5117-5117

2010

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled phase II study of the efficacy and safety of farletuzumab (MORAb-003) in combination with weekly paclitaxel in subjects with platinum-resistant or refractory relapsed ovarian cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.TPS255-TPS255

2010

Volltextzugriff (PDF)

Bilateral postpartum vulvar edema associated with maternal death

American journal of obstetrics and gynecology, 1987-05, Vol.156 (5), p.1188-1189

1987

Volltextzugriff (PDF)

Elevated CA 125 serum levels and epithelial ovarian cancer metastatic to retroperitoneal lymph nodes

Gynecologic oncology, 1988-03, Vol.29 (3), p.356-360

1988

Volltextzugriff (PDF)

Randomized phase III study of canfosfamide (C, TLK286) plus pegylated liposomal doxorubicin (PLD) versus PLD as second-line therapy in platinum (P) refractory or resistant ovarian cancer (OC)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.5552-5552

2009

Volltextzugriff (PDF)

Phase II multicenter trial of the histone deactylase inhibitor (HDACi) belinostat, carboplatin and paclitaxel (BelCaP) in patients (pts) with relapsed epithelial ovarian cancer (EOC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5519-5519

2008

Volltextzugriff (PDF)

Asystolic cardiac arrest: a rare complication of laparoscopy

Obstetrics and gynecology (New York. 1953), 1992-05, Vol.79 (5 ( Pt 2)), p.840

1992

Volltextzugriff (PDF)

Human anti-murine antibody responses in ovarian cancer patients undergoing radioimmunotherapy with the murine monoclonal antibody OC-125

Gynecologic oncology, 1990-08, Vol.38 (2), p.244-248

1990

Volltextzugriff (PDF)

Doxil and gemcitabine combination therapy for recurrent ovarian cancer: Results of a phase II trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5090-5090

2004

Volltextzugriff (PDF)

Doxil and gemcitabine combination therapy for recurrent ovarian cancer: Results of a phase II trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.5090-5090

2004

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(62)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(32)
Humans
(29)
Female
(27)
Obstetrics & Gynecology
(20)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Adult
(17)
Gynecology. Andrology. Obstetrics
(14)
Aged
(13)
Middle Aged
(13)
Tumors
(12)
Female Genital Diseases
(11)
Oncology
(11)
Hematology, Oncology And Palliative Medicine
(8)
Obstetrics And Gynecology
(7)
Aged, 80 And Over
(5)
Male
(5)
Ovarian Neoplasms - Immunology
(5)
Antibodies, Monoclonal - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of residual mass size on response to chemotherapy after surgical cytoreduction for advanced ovarian cancer: Long‐term results

Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses

A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma

Mucinous Adenocarcinomas of the Vulva

Paraovarian leiomyosarcoma with scalp metastasis: a case report

Clinical utility of CA 125 in preoperative diagnosis of patients with pelvic masses

Sonographic accuracy in the diagnosis of ovarian masses

Placental site trophoblastic tumor. Diagnosis, clinical behavior and treatment

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

Colouterine fistula complicating diverticulitis: charcoal challenge test aids in diagnosis

Clinical experience with placental site trophoblastic tumors at the New England Trophoblastic Disease Center

Intraperitoneal radioimmunotherapy of refractory ovarian carcinoma utilizing iodine-131-labeled monoclonal antibody OC125

Occult pleural involvement in Stage III ovarian carcinoma: Role of diaphragm resection

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC)

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC)

Chemoradiation followed by adjuvant hysterectomy for the treatment of stage IB-2 cervical cancer: 10-year experience

A randomized, double-blind, placebo-controlled phase II study of the efficacy and safety of farletuzumab (MORAb-003) in combination with weekly paclitaxel in subjects with platinum-resistant or refractory relapsed ovarian cancer

Bilateral postpartum vulvar edema associated with maternal death

Elevated CA 125 serum levels and epithelial ovarian cancer metastatic to retroperitoneal lymph nodes

Randomized phase III study of canfosfamide (C, TLK286) plus pegylated liposomal doxorubicin (PLD) versus PLD as second-line therapy in platinum (P) refractory or resistant ovarian cancer (OC)

Phase II multicenter trial of the histone deactylase inhibitor (HDACi) belinostat, carboplatin and paclitaxel (BelCaP) in patients (pts) with relapsed epithelial ovarian cancer (EOC)

Asystolic cardiac arrest: a rare complication of laparoscopy

Human anti-murine antibody responses in ovarian cancer patients undergoing radioimmunotherapy with the murine monoclonal antibody OC-125

Doxil and gemcitabine combination therapy for recurrent ovarian cancer: Results of a phase II trial

Doxil and gemcitabine combination therapy for recurrent ovarian cancer: Results of a phase II trial

Suchergebnisse filtern